Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

The Irritable Bowel Syndrome (IBS): A Market Analysis

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 02, 2006

The Doctor's Guide to Gastrointestinal Health : Preventing and Treating Acid Reflux, Ulcers, Irritable Bowel Syndrome, Diverticulitis, Celiac Disease, ... Pancreatitis, Cirrhosis, Hernias and more


This month's issue of Nature Reviews: Drug Discovery features an analysis of the Irritable bowellinks Syndrome (IBS) market.

IBS has received considerable attention recently for both its costs in terms of societal expenditures and for the realization that an effective therapy is possible. The economic consequences of IBS are substantial not only because of direct medical care costs, but also as a result of time and productivity lost at work. The annual direct and indirect medical costs of IBS management in the US have been reported to be as high as US$8 billion and $25 billion respectively. These costs place IBS among the 10 most expensive gastrointestinal (GI) diseases in the US. Yet only 6% of the direct costs are attributed to medication (compare this to gastroesophageal reflux disease (GERD), for which drug costs are estimated at 63% of total direct costs), making IBS a relatively under-penetrated market. Given its 12% prevalence and assuming 50% penetration, 7 (30-day) prescriptions per year and pricing in line with Novartis' tegaserod, IBS could represent a market on par with the current GERD ($15 billion) and depression ($14 billion) markets.


Read more of the analysis from Drug Discovery. The article is well-documented and discusses current treatment options as well as future market potentials. Note that the article was written by two representatives from the Dynogen Pharmaceuticals, Inc, a biopharmaceutical firm developing drugs for gastrointestinal disorders, including IBS.



Advertisement


Permalink: The Irritable Bowel Syndrome (IBS): A Market Analysis
Tags: IBS  gastrointestinal  biotech  market  analysis  market+analysis  bowel+syndrome  irritable+bowel 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/17415



Advertisement


Advertisement


RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter

Use the search to look for other interesting posts

 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give Luis a call at +1 (650) 331 8047.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network







 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells